100 related articles for article (PubMed ID: 10420152)
1. Elastin gene expression in benign prostatic hyperplasia.
Djavan B; Lin V; Seitz C; Kramer G; Kaplan P; Richier J; Marberger M; McConnell JD
Prostate; 1999 Sep; 40(4):242-7. PubMed ID: 10420152
[TBL] [Abstract][Full Text] [Related]
2. Decreased elastin gene expression in noncompliant human bladder tissue: a competitive reverse transcriptase-polymerase chain reaction analysis.
Djavan B; Lin V; Kaplan EP; Richier JC; Shariat S; Marberger M; McConnell JD
J Urol; 1998 Nov; 160(5):1658-62. PubMed ID: 9783926
[TBL] [Abstract][Full Text] [Related]
3. Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue.
Lin VK; Wang D; Lee IL; Vasquez D; Fagelson JE; McConnell JD
Prostate; 2000 Aug; 44(3):193-203. PubMed ID: 10906735
[TBL] [Abstract][Full Text] [Related]
4. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
Zhao H; Ramos CF; Brooks JD; Peehl DM
J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
[TBL] [Abstract][Full Text] [Related]
5. Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis.
Luo J; Dunn T; Ewing C; Sauvageot J; Chen Y; Trent J; Isaacs W
Prostate; 2002 May; 51(3):189-200. PubMed ID: 11967953
[TBL] [Abstract][Full Text] [Related]
6. Alpha-blockade downregulates myosin heavy chain gene expression in human benign prostatic hyperplasia.
Lin VK; Benaim EA; McConnell JD
Urology; 2001 Jan; 57(1):170-5. PubMed ID: 11164176
[TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of benign prostatic hyperplasia using a large scale real-time reverse transcriptase-polymerase chain reaction approach.
Fromont G; Chene L; Latil A; Bieche I; Vidaud M; Vallancien G; Mangin P; Fournier G; Validire P; Cussenot O
J Urol; 2004 Oct; 172(4 Pt 1):1382-5. PubMed ID: 15371850
[TBL] [Abstract][Full Text] [Related]
8. Real-time quantitative reverse transcriptase-polymerase chain reaction for luteinizing hormone-releasing hormone receptor gene mRNA expression in human prostate cancer.
Straub B; Müller M; Krause H; Schrader M; Miller K
Urology; 2003 Jul; 62(1):172-6. PubMed ID: 12837461
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of NKX3.1 in benign prostatic hyperplasia.
Irer B; Toylu A; Aslan G; Celebi I; Yorukoglu K; Atabey N
Urology; 2009 May; 73(5):1140-4. PubMed ID: 18597829
[TBL] [Abstract][Full Text] [Related]
10. Alpha(2) macroglobulin, a PSA binding protein, is expressed in human prostate stroma.
Lin VK; Wang SY; Boetticher NC; Vazquez DV; Saboorian H; McConnell JD; Roehrborn CG
Prostate; 2005 May; 63(3):299-308. PubMed ID: 15611997
[TBL] [Abstract][Full Text] [Related]
11. Real-time RT-PCR for the measurement of prostate-specific antigen mRNA expression in benign hyperplasia and adenocarcinoma of prostate.
Gelmini S; Tricarico C; Petrone L; Forti G; Amorosi A; Dedola GL; Serio M; Pazzagli M; Orlando C
Clin Chem Lab Med; 2003 Mar; 41(3):261-5. PubMed ID: 12705330
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
[TBL] [Abstract][Full Text] [Related]
13. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
14. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
Chakrabarti R; Robles LD; Gibson J; Muroski M
Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation.
Kramer G; Steiner GE; Handisurya A; Stix U; Haitel A; Knerer B; Gessl A; Lee C; Marberger M
Prostate; 2002 Jun; 52(1):43-58. PubMed ID: 11992619
[TBL] [Abstract][Full Text] [Related]
16. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
[TBL] [Abstract][Full Text] [Related]
17. [The mRNA expression of P16(ink4a) and HST2 in benign prostatic hyperplasia tissues: a pilot study].
Xiong Y; Pan TJ; Ye ZQ
Zhonghua Nan Ke Xue; 2008 Mar; 14(3):224-6. PubMed ID: 18488334
[TBL] [Abstract][Full Text] [Related]
18. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.
Cordon-Cardo C; Koff A; Drobnjak M; Capodieci P; Osman I; Millard SS; Gaudin PB; Fazzari M; Zhang ZF; Massague J; Scher HI
J Natl Cancer Inst; 1998 Sep; 90(17):1284-91. PubMed ID: 9731735
[TBL] [Abstract][Full Text] [Related]
19. Expression of basic fibroblast growth factor and its receptors FGFR1 and FGFR2 in human benign prostatic hyperplasia treated with finasteride.
Sáez C; González-Baena AC; Japón MA; Giráldez J; Segura DI; Rodríguez-Vallejo JM; González-Esteban J; Miranda G; Torrubia F
Prostate; 1999 Jul; 40(2):83-8. PubMed ID: 10386468
[TBL] [Abstract][Full Text] [Related]
20. Expression of mRNA for human type-I LHRH receptor transcript forms in human benign prostatic hyperplasia.
Rózsa B; Juhász A; Treszl A; Tóth G; Flaskó T; Dezsö B; Block NL; Schally AV; Halmos G
Int J Oncol; 2009 Nov; 35(5):1053-9. PubMed ID: 19787259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
